Arkolith/Insider Trading/FNCH/Form 4

Blaustein Marc

Chief Operating OfficerFinch Therapeutics Group, Inc. (FNCH) · full profile →Form 4 · filed Feb 23, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 21, 2023Sell(S)5K$0.38$2K28K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-005985) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML